||Naphthalene Toxicity in CD-1 Mice: General Toxicology and Immunotoxicology.
Shopp, G. M. ;
White, K. L. ;
Holsapple, M. P. ;
Barnes, D. W. ;
Duke, S. S. ;
||Medical Coll. of Virginia, Richmond. Dept. of Pharmacology. ;East Carolina Univ., Greenville, NC. School of Medicine.;Health Effects Research Lab., Research Triangle Park, NC.
Environmental surveys ;
Laboratory animals ;
||Some EPA libraries have a fiche copy filed under the call number shown.
The purpose of this study was to evaluate the acute and subchronic toxicity, and effects on immune function, of naphthalene (NAP) in random-bred CD-1 mice. The acute oral LD50 of this compound was 533 and 710 mg/kg in male and female mice, respectively. Fourteen- and ninety-day daily oral gavage studies were conducted. A dose of 1/2 the LD50 for 14 days resulted in decreased body weight and decreased spleen and thymus weight in females and males, respectively. Doses of up to 1/4 the LD50 for 90 days resulted in no dose related natalities or decreases in body weight. A dose dependent decrease in aryl hydrocarbon hydroxylase was seen. The immunological parameters assessed (i.e. humoral immunity, cell-mediated immunity, lymphocyte responsiveness and bone marrow function) were not affected in these subchronic studies.